We have successfully advised on the sale of Marsden Weighing Group to Alcuin Capital Partners

  1. Home
  2. Latest
  3. Sale of Marsden Weighing Group

We have successfully advised on the sale of Marsden Weighing Group to Alcuin Capital Partners

We have successfully advised on the sale of Marsden Weighing Group to Alcuin Capital Partners

We have successfully advised on the sale of Marsden Weighing Group to Alcuin Capital Partners, and the management team, led by managing director Richard Black.

Marsden, founded over 90 years ago, are a leading manufacturer of weighing scales with a global reach providing a bespoke weighing scale manufacturing service to 23 countries worldwide. Marsden are relied upon by both the medical profession, as the leading supplier of weighing equipment to hospitals, and industry generally, by supplying a range of products from veterinary to industrial scales.

"The sale will allow Marsden to transition into a new chapter of increased growth with the backing of Alcuin and a new management team as the long-time family shareholders step away from the company."

2 separate EMW teams advised the exiting shareholders and the new management team on this transaction.

The EMW sale side team was led by Gurpreet Sanghera and was assisted by Will Taylor, Habiba Kasker, Amanda deBruyn, Nick Ripper, and Tariq Sayfoo.

The EMW management team was led by Ian Morris and was assisted by Kerry Jimenez and Hollie Tompkins.

RSM’s M&A and Private Equity team advised the exiting shareholders of Marsden and Castle Corporate Finance advised the incumbent management team on the terms being offered by Alcuin.

Sally Tooher, exiting family shareholder of Marsden, said: “EMW and Gurpreet Sanghera in particular have been the nicest and most efficient people to help us through this complex transaction. They were supportive and understanding of our desires for the future of Marsden and our staff members and guided us all through the whole process with ease. Gurpreet and the EMW team formed excellent relationships with the Sellers, Buyer and RSM to ensure a smooth transition to sale and we the Sellers thank them”.

Gurpreet Sanghera, Principal in the Corporate team at EMW, commented: “I was involved from the outset. I had the pleasure of constructing the deal team for this transaction and supported the shareholders from start to finish. It started as a conversation with the retiring shareholders on how they could achieve a sale whilst ensuring that Marsden continued to grow its strong brand reputation within the UK and globally. RSM’s expert advice and guidance found the right strategic partner to support the management team and they provided invaluable support to the exiting shareholders throughout the whole process. It was important that Management had their own independent advice on the terms offered by Alcuin and Castle Corporate Finance’s impartial advice to management was key in getting the right deal for all the parties. With Richard continuing to lead the management team, supported by Alcuin as strategic partner the retiring family shareholders have certainly achieved their objective. This is an exciting time for Marsden as they embark on the global launch of their market leading product. We look forward to continuing to work with Marsden on future projects.”

Richard Black, Managing Director of Marsden, said: “EMW did a great job in representing the management team; they handled difficult negotiations expertly with the minimum of fuss and with a true collaborative approach, all of which were critical to getting the deal done. We would like EMW to work with Marsden’s management team right through to our ultimate exit.”

Nick Seaman, partner at Alcuin Capital Partners, commented: “Marsden is going through an exciting period of growth having recently launched a unique product to the global medical market. This represents the first of an exciting pipeline of NPD. We are delighted to be supporting the business to take both these new products and their existing product base to the NHS and healthcare organisations globally.”

Stephen Orriss, corporate finance partner for RSM, said: “It’s been a pleasure working with the Marsden shareholders to help them achieve their exit aspirations and to find a partner to support the continued growth of the business.” Clodagh Tunney CF Director for RSM added “We wish the shareholders, Alcuin and the management team all the best as they start this new chapter.”

Victoria Ansell, director of Castle, commented: “It is so important that the views of management are not overlooked when negotiating terms with a financial buyer. Such terms will, quite frankly, have a far greater impact on the team going forward, than they will on the sellers. RSM and EMW were engaged by the sellers, and recognised the need for the management team to have independent advice. Castle were pleased to step in, providing impartial and commercial advice, helping assess the implications of the terms offered by the funding partner they were taking on, with the management’s interest front and foremost."

Our corporate team advise companies, management teams, investors and debt providers from business start-ups and first round finance agreements through to mergers and acquisitions, management buy outs, development funding and then selling.

If you would like to find out more about this deal, please contact Gurpreet Sanghera or you can give us a call on 0345 070 6000.